Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479242 · ClinicalTrials.gov registry record
Diabetic Foot Ulcer Recurrence: Pilot Study
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 15
- Enrollment target
NCT03479242: Clinical Trial study, sponsored by Indiana University.
NCT03479242 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03479242 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
In this prospective pilot study, patients with DFU visiting the Indiana University Comprehensive Wound Center will be enrolled. Patients enrolled in the study will be followed for 16 weeks for wound closure(Phase A), and will then begin Phase B where TEWL measurements and wound recurrence will be followed up for up to 12 weeks.
Primary Outcome
TEWL will be measured to check for functional wound closure and see if DFU recidivism is high in subjects with a history of biofilm infection
Interventions
- OTHER no interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2023-08-30 |
Why NCT03479242 stopped before completion
NCT03479242 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which no interventions is the first listed.
NCT03479242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03479242 about?
NCT03479242 is a clinical study titled "Diabetic Foot Ulcer Recurrence: Pilot Study". In this prospective pilot study, patients with DFU visiting the Indiana University Comprehensive Wound Center will be enrolled. Patients enrolled in the study will be followed for 16 weeks for wound closure(Phase A), and will then begin Phase B where TEWL measurements and wound recurrence will be fo...
What is the current status of trial NCT03479242?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2019-01-25. Estimated completion is 2023-08-30.
What interventions are being tested in trial NCT03479242?
The interventions under investigation include: no interventions (OTHER).
Who is sponsoring clinical trial NCT03479242?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI